» Articles » PMID: 1373734

Direct Evidence for Increased Continuous Histamine Release in the Striatum of Conscious Freely Moving Rats Produced by Middle Cerebral Artery Occlusion

Overview
Publisher Sage Publications
Date 1992 May 1
PMID 1373734
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular histamine in the stratum of conscious freely moving rats collected by intracerebral microdialysis 1 day after implantation of a U-shaped dialysis probe was measured by HPLC coupled with postcolumn o-phthalaldehyde derivatization fluorometry. The basal fractional histamine outputs were almost constant from 1 to 7 h after the start of perfusion (5.9-8.4 pg/30 min). Depolarization by perfusion with a high K+ (100 mM)-containing medium produced a significant (124%) increase and neuronal blockade by perfusion with a tetrodotoxin (1 microM)-containing medium resulted in a 68% reduction in the histamine output. The histamine output was markedly reduced by intraperitoneal injection of alpha-fluoromethylhistidine (100 mg/kg), an irreversible inhibitor of histidine decarboxylase, or (R)-alpha-methylhistamine (5 mg/kg), a potent and specific H3-receptor agonist. After middle cerebral artery (MCA) occlusion, the histamine output gradually increased, and reached four times the control value 8 h later. When rats were pretreated with metoprine (10 mg/kg), a histamine N-methyltransferase inhibitor, there was no significant difference in the histamine output between the MCA-occluded and the sham-operated groups during the first 3.5 h after the operation, but the histamine output gradually increased thereafter in the MCA-occluded group. In rats treated with alpha-fluoromethylhistidine, MCA occlusion failed to cause an increase in the histamine output. These results demonstrate that MCA occlusion induces a long-lasting increase in neuronal histamine release in the rat striatum.

Citing Articles

Nicotine Exposure Along with Oral Contraceptive Treatment in Female Rats Exacerbates Post-cerebral Ischemic Hypoperfusion Potentially via Altered Histamine Metabolism.

dAdesky N, Diaz F, Zhao W, Bramlett H, Perez-Pinzon M, Dave K Transl Stroke Res. 2020; 12(5):817-828.

PMID: 33130995 DOI: 10.1007/s12975-020-00854-5.


Evaluation of a Portable Microchip Electrophoresis Fluorescence Detection System for the Analysis of Amino Acid Neurotransmitters in Brain Dialysis Samples.

Oborny N, Melo Costa E, Suntornsuk L, Abreu F, Lunte S Anal Sci. 2016; 32(1):35-40.

PMID: 26753703 PMC: 4875779. DOI: 10.2116/analsci.32.35.


Histamine and the striatum.

Bolam J, Ellender T Neuropharmacology. 2015; 106:74-84.

PMID: 26275849 PMC: 4917894. DOI: 10.1016/j.neuropharm.2015.08.013.


Role of histamine and its receptors in cerebral ischemia.

Hu W, Chen Z ACS Chem Neurosci. 2012; 3(4):238-47.

PMID: 22860191 PMC: 3369804. DOI: 10.1021/cn200126p.


Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives.

Bhowmik M, Khanam R, Vohora D Br J Pharmacol. 2012; 167(7):1398-414.

PMID: 22758607 PMC: 3514756. DOI: 10.1111/j.1476-5381.2012.02093.x.